Updates to the Statewide Preferred Drug List: Bausch, Fera, Oceanside Pharmaceuticals

March 27, 2026

Effective March 16, 2026, the Medical Assistance Program discontinued coverage of drugs manufactured by Bausch Health US (57782), Fera Pharmaceuticals (48102), and Oceanside Pharmaceuticals (68682) because these manufacturers no longer participate in the Medicaid Drug Program. As a result, their products are no longer eligible for prior authorization.

Medicines Excluded from PDL*

Preferred Alternatives Available

Cromolyn sodium spray 5.2/act

Azelastine 0.1% (137 mcg) Nasal Spray (generic Astelin), Fluticasone Propionate Nasal Spray (Rx), Ipratropium Nasal Spray

Phospholine solution 0.125% ophthalmic

Alphagan P 0.1% or 0.15% Drop, Brimonidine 0.2% Drop, Carteolol Drop, Combigan Drop, Dorzolamide Drop, Dorzolamide-Timolol Drop (generic Cosopt) Latanoprost 0.005% Drop, Levobunolol Drops, Simbrinza Drop, Timolol Maleate Drop (generic Timoptic)

*This list is not inclusive of all drugs manufactured by Bausch Health US, Fera Pharmaceuticals, and Oceanside Pharmaceuticals

For the most current formulary information, please visit HPPlans.com/formularies. For additional assistance, contact our Pharmacy Department at 215‑991‑4300 or Provider Services at 1‑888‑991‑9023 (Monday–Friday, 9 a.m.–5 p.m.).